Sinocare, Inc.

Headquarters: Changsha, China

Employees: 3,138

show_chart SZSE: 300298 -0.68%

Market Cap

CN¥20.23 Billion

CNY as of Jan. 1, 2023

US$2.93 Billion

history Market Cap History

Sinocare, Inc. market capitalization over time

Evolution of Sinocare, Inc. market cap in the past 5 years

Market capitalizations are calculated from the opening stock price at the beginning of each month.

history Market Cap History of Sinocare, Inc.

Detailed Description

Sinocare Inc. engages in the development, manufacture, and marketing of diagnosis rapid testing products primarily in the People's Republic of China. It offers SARS-CoV-2 antibody test strip; Safe-Accu blood glucose monitoring systems; Safe-AQ blood glucose monitoring systems; Gold-Accu blood glucose monitoring systems; Safe-Accu UG blood, glucose, and uric acid monitoring systems; Safe-Accu KG blood, glucose, and ketone monitoring systems; and D Nurse mobile glucose meters. The company provides its products for the patients with chronic diseases and diabetes, as well as for healthcare professionals. It also exports its products to 135 countries. Sinocare Inc. was founded in 2002 and is based in Changsha, the People's Republic of China.

Stocks & Indices

Sinocare, Inc. has the following listings and related stock indices.

Stock: SZSE: 300298



No. 265 Guyuan Road

Hi-tech Zone

Changsha, 410205


Phone: 86 731 8993 5581